| Identification | Back Directory | [Name]
1,5-Benzoxazepin-4(5H)-one, 3-[3-bromo-2,4,5,7-tetrahydro-7-oxo-2-(phenylmethyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-2,3-dihydro-5-methyl-, (3S)- | [CAS]
2095514-84-2 | [Synonyms]
TP-030-2
1,5-Benzoxazepin-4(5H)-one, 3-[3-bromo-2,4,5,7-tetrahydro-7-oxo-2-(phenylmethyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-2,3-dihydro-5-methyl-, (3S)- | [Molecular Formula]
C23H21BrN4O3 | [MOL File]
2095514-84-2.mol | [Molecular Weight]
481.34 |
| Chemical Properties | Back Directory | [Boiling point ]
758.0±60.0 °C(Predicted) | [density ]
1.55±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
0.29±0.40(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
TP-030-2 is a RIPK1 inhibitor (human Ki=0.43 nM; mouse IC50=100 nM)[1][2]. | [References]
[1] Yoshikawa M, et al. Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships. J Med Chem. 2018 Mar 22;61(6):2384-2409. DOI:10.1021/acs.jmedchem.7b01647
[2] https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/TP-030-2 |
|
|